I agree that this site is using cookies. You can find further informations here.
X
Mulgaonkar, Shamkant
8  results:
OpenAccess-fulltext X
Search for persons X
?
1

Two-year outcomes in de novo renal transplant recipients re..:

Berger, Stefan P ; Sommerer, Claudia ; Witzke, Oliver...
https://research.rug.nl/en/publications/42a0f34f-ad67-4345-a1f6-121aa0fc9aa8.  , 2019
Link: https://hdl.handle.net/1..
 
?
2

Everolimus with Reduced Calcineurin Inhibitor Exposure in R..:

Pascual, Julio ; Berger, Stefan P ; Witzke, Oliver...
https://research.rug.nl/en/publications/52f22ec7-876a-4a07-9c14-45289f89db88.  , 2018
Link: https://hdl.handle.net/1..
 
?
3

Everolimus with Reduced Calcineurin Inhibitor Exposure in R..:

Pascual, Julio ; Berger, Stefan P ; Witzke, Oliver...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6050928/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
4

Characteristics of compatible pair participants in kidney p..:

Weng, Francis L ; Grogan, Tracy ; Patel, Anup M..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831242/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
5

Health care follow-up by live kidney donors more than 3 yea..:

Weng, Francis L ; Reese, Peter P ; Waterman, Amy D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3692290.  , 2012
Link: http://www.ncbi.nlm.nih...
 
?
6

Barriers to Living Donor Kidney Transplantation among Black..:

Weng, Francis L ; Reese, Peter P ; Mulgaonkar, Shamkant.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2994097.  , 2010
Link: http://www.ncbi.nlm.nih...
 
?
7

Pharmacokinetics, safety, and efficacy of mycophenolate mof..:

Pescovitz, Mark D ; Vincenti, Flavio ; Hart, Marquis...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2198786.  , 2007
Link: http://www.ncbi.nlm.nih...
 
?
8

Outcomes in Ethnic Minority Renal Transplant Recipients Rec..:

Melancon, Keith ; Mulgaonkar, Shamkant P ; Delcoro, Carlos...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888463.  , 2013
Link: http://www.ncbi.nlm.nih...
 
1-8